about
New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilastVascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasisIn search of oral psoriasisTopical treatments for scalp psoriasisAntistreptococcal interventions for guttate and chronic plaque psoriasisOral fumaric acid esters for psoriasisIndoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasisSystemic pharmacological treatments for chronic plaque psoriasisComplementary therapies for chronic plaque psoriasisOral fumaric acid esters for psoriasisGene from a psoriasis susceptibility locus primes the skin for inflammationUstekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primerPromising new treatments for psoriasisLifting the silver flakes: the pathogenesis and management of chronic plaque psoriasisPsoriasis genetics: breaking the barrierPsoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique backgroundRelationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?MicroRNAs in autoimmune diseasesPutting together the psoriasis puzzle: an update on developing targeted therapiesModelling epidermis homoeostasis and psoriasis pathogenesis.Efalizumab binding to the LFA-1 L I domain blocks ICAM-1 binding via steric hindranceRoles of Erythroid Differentiation Regulator 1 (Erdr1) on Inflammatory Skin DiseasesPsoriasis: classical and emerging comorbiditiesThe Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasisMaturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytesGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanismsNovel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approachIMQ Induced K14-VEGF Mouse: A Stable and Long-Term Mouse Model of Psoriasis-Like InflammationAssessment of Anti-TNF-α Activities in Keratinocytes Expressing Inducible TNF- α: A Novel Tool for Anti-TNF-α Drug ScreeningAnti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with PsoriasisCombined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility lociGenome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at RELIdentification of ZNF313/RNF114 as a novel psoriasis susceptibility genePediatric Psoriasis.Co-morbidity in psoriasis: mechanisms and implications for treatment.Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis.Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis.Rationale and early clinical data on IL-17 blockade in psoriasis.Replication of association between ADAM33 polymorphisms and psoriasis.Diagnosis and management of psoriasis.
P2860
Q22305855-41802387-F67A-4D56-8F02-0C1EFEB3A142Q22305863-25C12571-53E9-443B-9062-E82220BEC6AAQ22337450-4CCB3905-B28C-4825-AB39-49613C405DCEQ24186104-73A9DF7B-32CB-443F-B118-3E19F921F9D2Q24187790-83AA38A4-19F3-45FC-BF2C-42E88DDFC913Q24187957-71EC99A8-22ED-4581-AF9D-E69EBBA45544Q24188256-3609B3C3-BF70-4038-B5C5-D9A0A2670FF7Q24188334-B719C374-E4D4-4552-A114-0802ED4BFF2BQ24194968-164A5042-FCAC-4382-A94A-AE9AE3392BBFQ24198185-D6CC15B6-21AA-443E-AD25-A02D7D638714Q24314913-C5014EE9-9C41-4CD5-B3B1-4833858103F3Q24596756-20578351-24E3-4860-9CAA-734BC7E311EDQ24598008-99A961DF-B1B4-4EBF-BDDD-4D05BCD51ADAQ24626968-6AE997AF-BEEF-4F99-85A2-7CE0AF29EF92Q24629796-C207952D-000E-4CA7-8746-42266FB78312Q26765175-07BAA7E1-2ECC-4517-8761-01DD33969FA0Q26767276-CCE3EF4E-BB52-4D2D-B02E-45CDC0F50CD6Q26824814-7F57E69F-8DA8-4F66-BC5C-6ACFE8D2C8BCQ27026785-B8E6F012-7ADB-443C-9B41-D5AAB72F6229Q27346151-FC4F64D0-9D48-444B-9C2A-EEDCFCB4CA3DQ27654007-404AC5F2-1617-44C7-A1BC-5A4D4476C65BQ28074548-1EB99C27-CDA2-4E7E-BD7F-531F1F097254Q28088340-3BA33E4F-E2B7-4508-BCF5-7D430440E494Q28261494-707EF124-C233-433E-AE64-8B48C5404E83Q28269054-925EB6E0-97A9-4E29-8DC1-F52D80341DEAQ28385664-99EE73F0-3ED1-4CBF-8F7E-B231E68F6FBAQ28535430-796D34B3-6482-4AF1-8FB4-E9551D07FDC4Q28551673-F62A6E39-D51E-40C8-A109-D3175473EAC4Q28552630-E41CF80B-2AE9-4F86-832B-45401C28F9EBQ28554923-ADA1CDB1-CA9D-4CE0-8BC0-418C6B6A48BDQ28924378-39036E59-9E75-43D3-A4E8-2B4ACDF3F0CEQ28943423-E0E3607F-4830-432C-819E-1A744818B131Q28943483-160686B9-766C-4527-BD76-5707CD1A2C89Q30234370-DDBA2DFA-0CA7-47C0-A2A1-F6C28EB9058FQ30248952-E6515EC1-71B5-41D9-807B-AEECA1EE314BQ30373501-74798AEF-2C1B-4C35-BCCF-1EF30D5F5A84Q30420443-A0EF4AC6-6637-4690-A490-B8C4531B25DAQ30658185-0ACA4F22-7189-4FDE-ADCA-5FF78D11194FQ33344508-F22D1C6E-0831-4BC7-A518-64943C5F20D8Q33558495-75D6EC20-F4B1-45E3-AE9C-E05B1A5256A2
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pathogenesis and clinical features of psoriasis.
@en
type
label
Pathogenesis and clinical features of psoriasis.
@en
prefLabel
Pathogenesis and clinical features of psoriasis.
@en
P1433
P1476
Pathogenesis and clinical features of psoriasis.
@en
P2093
Christopher E M Griffiths
Jonathan N W N Barker
P304
P356
10.1016/S0140-6736(07)61128-3
P407
P577
2007-07-01T00:00:00Z